2008 Clinical Trials Treatment 
Project CBD
FEBRUARY 27, 2023
In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” It’s not a new idea. That seemed to make all the difference.
Greencamp
FEBRUARY 17, 2019
One study from 2004 looked at cannabinoids as a treatment option for managing bowel diseases symptoms (including IBS), because of their anti-inflammatory properties, but also the ability to diminish pain levels. Neuroendocrinology Letters; April 2008; 29(2):192-200. How to choose the best strain for IBS?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
NOVEMBER 15, 2020
research funders, the National Institute on Drug Abuse (NIDA) , spent over $1 billion between 2000 and 2008, with a heavily slanted focus on cannabis abuse and misuse, as well as the negative effects of cannabis. While some funds are being used to study cannabis medical treatments, the majority of funding is still used to research harms.
CannaMD
AUGUST 26, 2020
Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats).
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Cannabis Law Report
DECEMBER 6, 2021
–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO). Dr. Jacobs, who most recently served as CSO of Ardelyx, Inc.,
Cannabis Law Report
NOVEMBER 24, 2021
2018 ; Frankhauser 2008 ). It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). 2008 )—were difficult for any plant to compete with, especially one whose active constituents would not be revealed for another 30?years 2016 ; Sznitman et al. years (Atakan 2012 ).
Expert insights. Personalized for you.
144 
Let's personalize your content